KR880009550A - 4-치환된-2-아제티디논 화합물의 제조방법 - Google Patents

4-치환된-2-아제티디논 화합물의 제조방법

Info

Publication number
KR880009550A
KR880009550A KR1019870000409A KR870000409A KR880009550A KR 880009550 A KR880009550 A KR 880009550A KR 1019870000409 A KR1019870000409 A KR 1019870000409A KR 870000409 A KR870000409 A KR 870000409A KR 880009550 A KR880009550 A KR 880009550A
Authority
KR
South Korea
Prior art keywords
substituted
preparing
azetidinone compound
azetidinone
compound
Prior art date
Application number
KR1019870000409A
Other languages
English (en)
Other versions
KR890002105B1 (ko
Inventor
도시나리 다무라
히데노리 이와모도
마고또 요시다
미노루 야마모도
Original Assignee
야마노우찌 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58048989A external-priority patent/JPS59225182A/ja
Priority claimed from JP58221470A external-priority patent/JPS60115578A/ja
Priority claimed from JP58221469A external-priority patent/JPS60115577A/ja
Application filed by 야마노우찌 세이야꾸 가부시끼 가이샤 filed Critical 야마노우찌 세이야꾸 가부시끼 가이샤
Publication of KR880009550A publication Critical patent/KR880009550A/ko
Application granted granted Critical
Publication of KR890002105B1 publication Critical patent/KR890002105B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019870000409A 1983-03-25 1987-01-20 4-치환된-2-아제티디논 화합물의 제조방법 KR890002105B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP48989/83 1983-03-25
JP58048989A JPS59225182A (ja) 1983-03-25 1983-03-25 ２−アゼチジノン−４−カルボン酸の誘導体
JP58221470A JPS60115578A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換化合物
JP221469/83 1983-11-25
JP58221469A JPS60115577A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換体
JP221470/83 1983-11-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001506A Division KR870000357B1 (ko) 1983-03-25 1984-03-23 4-치환된-2-아제티디논 화합물의 제조 방법

Publications (2)

Publication Number Publication Date
KR880009550A true KR880009550A (ko) 1988-09-15
KR890002105B1 KR890002105B1 (ko) 1989-06-19

Family

ID=27293483

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019840001506A KR870000357B1 (ko) 1983-03-25 1984-03-23 4-치환된-2-아제티디논 화합물의 제조 방법
KR1019870000408A KR890002104B1 (ko) 1983-03-25 1987-01-20 4-치환된-2-아제티디논 화합물의 제조방법
KR1019870000409A KR890002105B1 (ko) 1983-03-25 1987-01-20 4-치환된-2-아제티디논 화합물의 제조방법

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR1019840001506A KR870000357B1 (ko) 1983-03-25 1984-03-23 4-치환된-2-아제티디논 화합물의 제조 방법
KR1019870000408A KR890002104B1 (ko) 1983-03-25 1987-01-20 4-치환된-2-아제티디논 화합물의 제조방법

Country Status (8)

Country Link
US (3) US4564609A (ko)
EP (1) EP0123444B1 (ko)
KR (3) KR870000357B1 (ko)
CA (1) CA1256650A (ko)
DE (1) DE3476399D1 (ko)
DK (1) DK164684A (ko)
ES (4) ES530960A0 (ko)
NO (1) NO158740C (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル
ZA868957B (en) * 1985-12-06 1987-07-29 Yamanouchi Pharma Co Ltd Crystals of nalpha-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamide and process for producing the crystals
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
DK437289D0 (da) * 1989-09-04 1989-09-04 Hans Bundgaard Prodrug derivatives of thyrotropin-releasing hormone (trh)
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
JP2001524132A (ja) * 1997-05-09 2001-11-27 スミスクライン・ビーチャム・コーポレイション ＣｏＡ−ＩＴのベータ−ラクタム阻害剤
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
EP1300155A1 (en) * 2000-07-11 2003-04-09 Shionogi & Co., Ltd. Enteric preparations containing physiologically active peptides
EP1321151A4 (en) 2000-08-31 2009-07-15 Shionogi & Co MEANS FOR THE TREATMENT OF PARKINSON
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
MXPA03006727A (es) * 2001-01-26 2003-10-24 Schering Corp Combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares.
CZ20032031A3 (cs) * 2001-01-26 2003-12-17 Schering Corporation Farmaceutický prostředek
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
CA2434430A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis The use of substituted azetidinone compounds for the treatment of sitosterolemia
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
SK288217B6 (sk) * 2001-01-26 2014-08-05 Merck Sharp & Dohme Corp. Zmes, terapeutická kombinácia, farmaceutický prostriedok a ich použitie
NZ542090A (en) * 2001-01-26 2006-09-29 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
EP1785144A3 (en) * 2001-01-26 2007-05-23 Shering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR038956A1 (es) * 2001-05-25 2005-02-02 Schering Corp Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
CA2460340C (en) * 2001-09-21 2011-02-15 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
PT1427409E (pt) * 2001-09-21 2008-11-27 Schering Corp Métodos para tratar ou para impedir a inflamação vascular utilizando inibidor(es) de absorção de esteróis
WO2004043457A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009501A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
WO2004081004A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
ATE406364T1 (de) * 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US20050096307A1 (en) * 2003-11-05 2005-05-05 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
KR101137503B1 (ko) * 2009-07-14 2012-04-20 웰이앤씨 주식회사 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법
CA2920770C (en) * 2013-08-16 2022-04-26 Los Alamos National Security, Llc Compounds and methods for improving plant performance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) * 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant

Also Published As

Publication number Publication date
ES8604136A1 (es) 1986-01-16
ES544234A0 (es) 1986-01-16
US4636567A (en) 1987-01-13
ES544236A0 (es) 1986-01-16
DK164684A (da) 1984-09-26
NO158740B (no) 1988-07-18
KR890002105B1 (ko) 1989-06-19
KR880009549A (ko) 1988-09-15
NO158740C (no) 1988-10-26
DK164684D0 (da) 1984-03-23
EP0123444B1 (en) 1989-01-25
US4564609A (en) 1986-01-14
NO841158L (no) 1984-09-26
ES8604209A1 (es) 1986-01-16
ES8600279A1 (es) 1985-10-01
ES544235A0 (es) 1986-01-16
CA1256650A (en) 1989-06-27
EP0123444A1 (en) 1984-10-31
KR890002104B1 (ko) 1989-06-19
ES530960A0 (es) 1985-10-01
KR840008021A (ko) 1984-12-12
KR870000357B1 (ko) 1987-03-05
DE3476399D1 (en) 1989-03-02
ES8604208A1 (es) 1986-01-16
US4610821A (en) 1986-09-09

Similar Documents

Publication Publication Date Title
KR880009549A (ko) 4-치환된-2-아제티디논 화합물의 제조방법
DK301986A (da) Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser
ES543655A0 (es) Metodo de preparar compuestos 1,4-dihidropiridinicos
DK169384D0 (da) Fremgangsmaade til fremstilling af(3s)-3,4-trans-disubstituerede azetidinoner
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
KR850002010A (ko) 헤테로사이클릭 화합물의 제조방법
DK154207C (da) Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner
KR860001044A (ko) 페닐 노나테트라에노산 유도체의 제조방법
DK23784D0 (da) Fremgangsmade til fremstilling af beta-lactam
DE3465987D1 (de) Process for preparing azetidinone derivatives
DK457983D0 (da) Fremgangsmade til fremstilling af beta-lactam
KR860004941A (ko) 아실-락탐화합물을 제조하는 방법
KR880701714A (ko) 질소 함유 헤테로시클릭 화합물의 제조방법
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
KR860004939A (ko) N-치환된 아실-락탐 화합물을 제조하는 방법
DK518883A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser
KR860003647A (ko) 아릴-치환된 이미다졸 화합물의 제조방법
DK190385D0 (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DE3463140D1 (de) Process for preparing azetidinone derivatives
KR860004940A (ko) N-치환된 아실-락탐 화합물을 제조하는 방법
DK156061C (da) Fremgangsmaade til fremstilling af 2-alkyl-4-amino-5-aminomethylpyrimidin
KR850003384A (ko) 9-카바모일플루오렌 유도체의 제조방법
KR840006000A (ko) 디플루오로메톡시 방향족 화합물의 제조방법
KR850003306A (ko) 알로파노일피페라진 화합물의 제조방법
DE3372613D1 (de) Process for preparing azetidinone derivatives

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19920526

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee